Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-12

Clinical Trial Update: Ketogenic Diet for New-Onset Absence Epilepsy [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the ketogenic diet for new-onset absence epilepsy is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketogenic Diet

Snippet

Sponsor: Johns Hopkins University | Conditions: Absence Epilepsy, Ketogenic Dieting | Phase 3 | Status: RECRUITING